高级检索
当前位置: 首页 > 详情页

Levels of Inflammatory Cytokines IL-1 beta, IL-6, IL-8, IL-17A, and TNF-alpha in Aqueous Humour of Patients with Diabetic Retinopathy

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Southern Med Univ, ZhuJiang Hosp, Dept Ophthalmol, Guangzhou 510280, Guangdong, Peoples R China; [2]Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Eye Inst, Dept Ophthalmol, Guangzhou 510080, Guangdong, Peoples R China; [3]Kunming Med Coll, Affiliated Hosp 1, Dept Ophthalmol, Kunming 650031, Yunnan, Peoples R China; [4]Gejiu Peoples Hosp, Gejiu 661000, Peoples R China; [5]Second Peoples Hosp Jiangxi, Nanchang 330000, Jiangxi, Peoples R China
出处:
ISSN:

摘要:
Diabetic retinopathy is the leading cause of blindness in working age individuals in developed countries. However, the role of inflammation in the pathogenesis of DR is not completely understood. This is an observational clinical research enrolling 80 type II diabetic patients who had undergone cataract surgeries either with DR or without DR. All cases were further categorized by the proliferative stages of retinal neovascularization and by the lengths of diabetic history. The levels of inflammatory cytokines including IL-1 beta, IL-6, IL-8, IL-17, and TNF-alpha in aqueous humour were tested. Results in this study indicated that these cytokine levels were increased in DR patients and might have a synergistic effect on the pathogenesis of this disease. They were also elevated along with the progression of neovascularization, reflecting the severity of DR. The results also suggested that for diabetic patients, the higher these levels are, the sooner retinal complications might appear. In conclusion, the levels of inflammatory cytokines IL-1 beta, IL-6, IL-8, IL-17A, and TNF-alpha in aqueous humour may be associated with the pathogenesis, severity, and prognosis of DR.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 3 区 医学
小类 | 3 区 医学:研究与实验 4 区 内分泌学与代谢
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 内分泌学与代谢 3 区 医学:研究与实验
JCR分区:
出版当年[2018]版:
Q2 MEDICINE, RESEARCH & EXPERIMENTAL Q3 ENDOCRINOLOGY & METABOLISM
最新[2023]版:
Q2 ENDOCRINOLOGY & METABOLISM Q2 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]Southern Med Univ, ZhuJiang Hosp, Dept Ophthalmol, Guangzhou 510280, Guangdong, Peoples R China;
通讯作者:
通讯机构: [3]Kunming Med Coll, Affiliated Hosp 1, Dept Ophthalmol, Kunming 650031, Yunnan, Peoples R China;
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:53621 今日访问量:17 总访问量:1665 更新日期:2024-11-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 昆明医科大学第一附属医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西昌路295号(650032)